论文信息 - A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors - 字舞流文

A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors

Mojun Zhu | A. Tan | A. Adjei | G. Dy | G. Croghan | Y. Qi | J. Molina | L. Hanson | M. Roos | J. Glockner